OU team gets grant to find new antibiotic
NORMAN — University of Oklahoma professors Helen Zgurskaya and Valentin Rybenkov and their team are addressing the critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.
The OU team responded to a request for applications from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and received a fiveyear, $5.7 million grant to develop new, more effective approaches against the bacterium.
The OU-led project, “Optimization of efflux avoidance and inhibition for antibiotic development,” is one of only four projects that received an NIH award for the development of new approaches to antibioticresistant bacteria. Harvard, Yale and the University of Illinois at Urbana-Champagne received the remaining three grants.